Novel antigens in non-small cell lung cancer: SP17, AKAP4, and PTTG1 are potential immunotherapeutic targets

Lung cancer is the leading cause of cancer deaths in both genders worldwide, with an incidence only second to prostate cancer in men and breast cancer in women. The lethality of the disease highlights the urgent need for innovative therapeutic options. Immunotherapy can afford efficient and specific...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirandola, Leonardo, Figueroa, Jose A., Phan, Tam T., Grizzi, Fabio, Kim, Minji, Rahman, Rakhshanda Layeequr, Jenkins, Marjorie R., Cobos, Everardo, Jumper, Cynthia, Alalawi, Raed, Chiriva-Internati, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413619/
https://www.ncbi.nlm.nih.gov/pubmed/25739119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413619/
https://www.ncbi.nlm.nih.gov/pubmed/25739119

Ejemplares similares